Toshiyuki Kameyama

Bisucaberin, a new siderophore, sensitizing tumor cells to macrophage-mediated cytolysis. II. Physico-chemical properties and structure determination.

Atsushi Takahashi, H. Nakamura, Toshiyuki Kameyama et al. · The Journal of Antibiotics · 1987 · 90 citations · Full text

Life Sciences, Medicinal Chemistry, Oncology +12

Bisucaberin, a new siderophore, sensitizing tumor cells to macrophage-mediated cytolysis. I. Taxonomy of the producing organism, isolation and biological properties.

Toshiyuki Kameyama, Atsushi Takahashi, SHOGO KURASAWA et al. · The Journal of Antibiotics · 1987 · 79 citations · Full text

Life Sciences, Cell Biology, Oncology +13

A new non-protein enediyne antibiotic N1999A2: Unique enediyne chromophore similar to neocarzinostatin and DNA cleavage feature

Toshihiko Ando, Makoto Ishii, Takayuki Kajiura et al. · Tetrahedron Letters · 1998 · 49 citations

Pharmacy, Medicinal Chemistry, Drug Discovery +8

Anisomycin and new congeners active against human tumor cell lines.

Y Hosoya, Toshiyuki Kameyama, HIROSHI NAGANAWA et al. · The Journal of Antibiotics · 1993 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

New Cyclic Depsipeptide Antibiotics, Clavariopsins A and B, Produced by an Aquatic Hyphomycetes, Clavariopsis aquatica.

Kenichi Kaida, Ryosuke Fudou, Toshiyuki Kameyama et al. · The Journal of Antibiotics · 2001 · 30 citations · Full text

Life Sciences, Biochemistry, Microbiology +12